Pharmaceutical companies are preparing for potential tariffs imposed by President Trump’s administration. The move adds to growing uncertainties in the sector, which is already facing changes under Secretary of Health and Human Services Robert F. Kennedy Jr.’s plans to overhaul the U.S. healthcare system. Eli Lilly, Vertex, and AbbVie are among the companies that may be affected.
Source: https://www.barrons.com/articles/pharma-stocks-tariffs-e7b96aaa